162 related articles for article (PubMed ID: 37958751)
1. Molecular Action of Tamoxifen in the Ovaries of Rats with Mammary Neoplasia.
Nynca A; Swigonska S; Molcan T; Petroff BK; Ciereszko RE
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958751
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen decreases ovarian toxicity without compromising cancer treatment in a rat model of mammary cancer.
Nynca A; Swigonska S; Ruszkowska M; Sadowska A; Orlowska K; Molcan T; Myszczynski K; Otrocka-Domagala I; Paździor-Czapula K; Kurowicka B; Petroff BK; Ciereszko RE
BMC Genomics; 2023 Jun; 24(1):325. PubMed ID: 37312040
[TBL] [Abstract][Full Text] [Related]
3. Effects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifen.
Dias MC; Furtado KS; Rodrigues MA; Barbisan LF
BMC Complement Altern Med; 2013 May; 13():93. PubMed ID: 23634930
[TBL] [Abstract][Full Text] [Related]
4. Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
Hilakivi-Clarke L; Wärri A; Bouker KB; Zhang X; Cook KL; Jin L; Zwart A; Nguyen N; Hu R; Cruz MI; de Assis S; Wang X; Xuan J; Wang Y; Wehrenberg B; Clarke R
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27609189
[TBL] [Abstract][Full Text] [Related]
5. Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study.
Yamazaki R; Inokuchi M; Ishikawa S; Ayabe T; Jinno H; Iizuka T; Ono M; Myojo S; Uchida S; Matsuzaki T; Tangoku A; Kita M; Sugie T; Fujiwara H
BMC Cancer; 2020 Jan; 20(1):67. PubMed ID: 31996163
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries.
Piasecka-Srader J; Blanco FF; Delman DH; Dixon DA; Geiser JL; Ciereszko RE; Petroff BK
Biol Reprod; 2015 May; 92(5):132. PubMed ID: 25833159
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
[TBL] [Abstract][Full Text] [Related]
8. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
Osipo C; Gajdos C; Cheng D; Jordan VC
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
[TBL] [Abstract][Full Text] [Related]
9. Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1.
Mahran YF; El-Demerdash E; Nada AS; Ali AA; Abdel-Naim AB
Endocrinology; 2013 Oct; 154(10):3888-99. PubMed ID: 23798597
[TBL] [Abstract][Full Text] [Related]
10. Effects of tamoxifen on autosomal genes regulating ovary maintenance in adult mice.
Yu M; Liu W; Wang J; Qin J; Wang Y; Wang Y
Environ Sci Pollut Res Int; 2015 Dec; 22(24):20234-44. PubMed ID: 26304810
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines.
Mandlekar S; Hebbar V; Christov K; Kong AN
Cancer Res; 2000 Dec; 60(23):6601-6. PubMed ID: 11118041
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Cancer Prev Res (Phila); 2008 Dec; 1(7):546-53. PubMed ID: 19139004
[TBL] [Abstract][Full Text] [Related]
13. Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
Kim HA; Lee JW; Nam SJ; Park BW; Im SA; Lee ES; Jung YS; Yoon JH; Kang SS; Lee SJ; Park KH; Jeong J; Cho SH; Kim SY; Kim LS; Moon BI; Lee MH; Kim TH; Park C; Jung SH; Gwak G; Kim J; Kang SH; Jin YW; Kim HJ; Han SH; Han W; Hur MH; Noh WC;
J Clin Oncol; 2020 Feb; 38(5):434-443. PubMed ID: 31518174
[TBL] [Abstract][Full Text] [Related]
14. Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model.
De Oliveira Andrade F; Yu W; Zhang X; Carney E; Hu R; Clarke R; FitzGerald K; Hilakivi-Clarke L
Endocr Relat Cancer; 2019 Mar; 26(3):339-353. PubMed ID: 30640711
[TBL] [Abstract][Full Text] [Related]
15. Ovarian status influences the skeletal effects of tamoxifen in adult rats.
Sibonga JD; Evans GL; Hauck ER; Bell NH; Turner RT
Breast Cancer Res Treat; 1996; 41(1):71-9. PubMed ID: 8932878
[TBL] [Abstract][Full Text] [Related]
16. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen and soluble tumor-associated antigens on ovarian structure in mammary tumor-bearing rats.
Kossoy G; Ben-Hur H; Elhayany A; Schneider DF; Kossoy N; Zusman I
Oncol Rep; 2005 Nov; 14(5):1317-21. PubMed ID: 16211303
[TBL] [Abstract][Full Text] [Related]
18. Maternal tamoxifen exposure leads to abnormal primordial follicle assembly.
Zhao J; Zhang J; Sun Y; Wang R; Shi D; Shen W; Sun X
Histochem Cell Biol; 2023 Aug; 160(2):97-111. PubMed ID: 37148333
[TBL] [Abstract][Full Text] [Related]
19. ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer.
Madhavan S; Gusev Y; Singh S; Riggins RB
J Exp Clin Cancer Res; 2015 May; 34(1):45. PubMed ID: 25971350
[TBL] [Abstract][Full Text] [Related]
20. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
